Abstract:Radiotherapy and chemotherapy are essential for preoperative and postoperative treatment of cancer patients. Chemotherapy drugs destroy cancer cells and inhibit their proliferation mainly by promoting cancer cell apoptosis. The efficacy of anticancer drugs is measured by their ability to recognize cancer cells and selectively promote their apoptosis. The Drug Sensitivity Test (DST) is a method to determine the most effective drug for tumor treatment according to the sensitivity. Tumors may be resistant to one or more drugs, or show sensitivity to multiple drugs for their different genotype and pathogenesis. Therefore, the detection of drug-induced apoptosis in anticancer drug sensitivity test is of great significance for reducing drug resistance, improving the efficiency of drug sensitivity test and achieving more effective personalized treatment. At present, the main methods to detect apoptosis are to detect the changes of cell morphology and surface markers related to apoptosis. However, the commonly used methods like flow cytometry, membrane protein, TUNEL analysis, have poor specificity in the detection of cell apoptosis. The typical morphological changes exhibited in the process of apoptosis which have become a reliable basis for the identification of apoptosis. Digital holographic microscopy provides a non-invasive quantitative phase imaging method for living cells. It can meet the requirements of label-free, long-term imaging, and evaluation of cell morphological and kinetic parameters under different treatments. In this paper, digital holographic microscopy is used to record images of label-free cancer cells during apoptosis process after adding drugs. Firstly, a Mach-Zehnder digital holographic microscopic system with an off-axis configuration is used to capture the wave-field of cancer cells. This system can realize complex object wavefront reconstruction with a single camera exposure. In the process of cell imaging, the cells adhere to the bottom of the cell culture dish, and the culture dish is filled with cell culture solution to ensure the normal growth of cells. The camera records a hologram every 1min for a total of 9 hours after adding drugs into the cell culture solution. Then, the phase images of cancer cells are numerically reconstructed. Two pre-processing operations are implemented, consisting of hologram apodization and spatial filtering and then the angle spectrum reconstruction algorithm is employed to implement the numerical propagation, keeping the object image size constant whatever the propagation distance. To obtain an in-focus and sharp object image, an optimal propagation distance needs to be found by automatic focus method. Besides, Numerical Parametric Lenses (NPL) method is employed to compensate the phase aberrations in the phase image. Due to the phase value reconstructed from the hologram constrained between- pi and pi, the continuous phase map of the object can be retrieved by phase unwrapping. From the reconstructed phase image of cells after 9 hours of drug treatment, it can be clearly seen that most of the cells have broken and died, while other cells that have not broken have also shrunk significantly, and the cell height has increased significantly. Furthermore, we select 8 cells from the dead cells for further analysis of their complete death process. Single-cell phase images are segmented from the phase images. And, the morphological change of cell apoptosis process is characterized morphologically by the average phase shift and dry mass. It can be seen from the change carves of these two parameters during the cell apoptosis, there is no obvious change of cell dry mass before apoptosis. But at the moment of the cells lose membrane integrity and release their intracellular contents, cells' dry mass decreased sharply. At the meantime, the average phase shift continuously increases before the cells lose membrane integrity, indicating that the cells have contracted, which is consistent with the conclusion in previous study. These results show that there are significant differences in phase images and morphological parameters between growing cancer cells and apoptotic and dead cells. Therefore, the method in this paper can distinguish apoptotic cells and dead cells without fluorescent labeling. And it can provide a more economical and convenient detection method for determining and selecting the most effective chemotherapeutic drugs and determining their effective dose for in vitro drug sensitivity test in individualized treatment.

Chemosensitivity testing of revived fresh-frozen biopsies using digital speckle holography

Abstract 320: Perfused 3D Tri-Culture Breast Cancer Microtumors for Accurate Prediction of Drug Response

Comparative oncology chemosensitivity assay for personalized medicine using low-coherence digital holography of dynamic light scattering from cancer biopsies

Establishing a Cryopreserved Biobank of Living Tumor Tissues for Drug Sensitivity Testing

Optimal methods for fluorescence and diffuse reflectance measurements of tissue biopsy samples

Impact of preanalytical factors on liquid biopsy in the canine cancer model

Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Transcriptome Analysis of Archived Tumor Tissues by Visium, GeoMx DSP, and Chromium Methods Reveals Inter- and Intra-Patient Heterogeneity

Spatial Omics Imaging of Fresh-Frozen Tissue and Routine FFPE Histopathology of a Single Cancer Needle Core Biopsy: A Freezing Device and Multimodal Workflow

DNA Quantity and Quality Comparisons between Cryopreserved and FFPE Tumors from Matched Pan-Cancer Samples

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

A transportable hyperspectral imaging setup based on fast, high-density spectral scanning for in situ quantitative biochemical mapping of fresh tissue biopsies

Single nucleus DNA sequencing of flow sorted archived frozen and formalin fixed paraffin embedded solid tumors

Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision Medicine

Abstract 326: Matched fresh frozen and FFPE patient tissues reveal the enhanced sensitivity and data quality of a novel DNA library prep method

Abstract 5027: Simplified selective electrochemical detection of ctDNA differentiates between cancer progression and regression

Whole Genome 3D Blood Biopsy Profiling of Canine Cancers: Development and Validation of EpiSwitch Multi-Choice Array-Based Diagnostic Test.

Abstract B005: Investigating distinct methylation signatures characteristic of breast cancer subtypes in residual disease via cell free DNA methylation

High‐throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification

Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients

Quantitative Monitoring of Morphological Change of Cancer Cells Apoptosis by Digital Holographic Microscopy(Invited)